Bristol-Myers Squibb Co Sustainability Reports
Bristol-Myers Squibb Company is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, and marketing of innovative medicines. The company primarily targets serious diseases across therapeutic areas such as oncology, cardiovascular health, immunology, and neuroscience.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: HLYYNH7UQUORYSJQCN42
FIGI: BBG001S8N8J6
38 reports from 2005 to 2025
